Supple_Figure_2.tiff (2.26 MB)
Suppl_Figure_2: Economic burden in treated Japanese patients with relapsed/refractory large B-cell lymphoma.tiff
figure
posted on 2021-08-20, 12:32 authored by Saaya Tsutsué, Shinichi Makita, Jingbo Yi, Bruce Crawford|
Supplemental Figure 2 - Claims between 1st March and 30th June 2019 for the pre-COVID-19 subgroup were analyzed in comparison with claims between 1st March and 30th June 2020 for the post-COVID-19 subgroup |
